On March 1, 2023 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in March (Press release, UroGen Pharma, MAR 1, 2023, View Source [SID1234627993]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cowen 43rd Annual Health Care Conference — March 7-9, 2023
Panel Presentation Date: Tuesday, March 7th from 12:50-1:50pm ET
Webcast Link: https://wsw.com/webcast/cowen132/panel12/2317014
Oppenheimer 33rd Annual Healthcare Conference — March 13-15, 2023
Presentation Date: Tuesday, March 14th from 10:40-11:10am ET
Webcast Link: View Source
Webcasts for both the Cowen and Oppenheimer presentations will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 30 days.